Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]
about
Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomesThe potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?Recent insights into atopic dermatitis and implications for management of infectious complications.Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.Therapeutic perspectives in atopic dermatitis.Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethalityBacillus anthracis edema toxin inhibits Staphylococcus aureus enterotoxin B effects in vitro: a potential protein therapeutic?Levels of alpha-toxin correlate with distinct phenotypic response profiles of blood mononuclear cells and with agr background of community-associated Staphylococcus aureus isolates.Kawasaki disease. The mystery continuesIntravenous immunoglobulin in neurological disease: a specialist review.Characterization of infecting strains and superantigen-neutralizing antibodies in Staphylococcus aureus bacteremia.Immunomodulatory action of intravenous immunoglobulin.Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferateEvidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivoIVIG in APS pregnancy.Necrotizing fasciitis: pathogenesis and treatment.Clinical uses of intravenous immunoglobulin.Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspectiveImmunoglobulin replacement therapy in children.Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.Clinical role for a superantigen in Yersinia pseudotuberculosis infection.Immunoglobulins in adult sepsis and septic shock.The expanding role of therapeutic antibodies.Staphylococcal scalded skin syndrome: diagnosis and management in children and adults.Intravenous immunoglobulin in necrotizing fasciitis - A case report and review of recent literature.Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.Necrotising fasciitis secondary to perforated rectal adenocarcinoma presenting as a thigh swelling.Superantigens and cystic fibrosis: resistance of presenting cells to dexamethasoneImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production.Bacterial pyrogenic exotoxins as superantigens.Commercial peptidoglycan preparations are contaminated with superantigen-like activity that stimulates IL-17 production.Commercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Leukocidin LukAB (LukGH).Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.Intravenous IgG: supertherapy for superantigens?IVIG-mediated protection against necrotizing pneumonia caused by MRSA.
P2860
Q28395996-5BE74C34-CFE8-43DA-9ED3-80A085C81B34Q30415990-76F16A91-4092-419D-A527-6420A377F55BQ30752612-FBE211C8-5011-4018-9146-7B8985DB8B71Q33364381-9ABA9C4A-F920-4546-AF8A-0B10BAA4CC02Q33621496-B36A7AB6-CE2A-4D51-8CA3-68854C049FA6Q33719201-D8130830-B15A-48E6-B89E-5FC832DEB5D1Q33753988-969BB752-F80F-443D-A4BD-25CFE8FEB34EQ33874346-1350014A-D7D0-4D65-AEC6-534FF6E03F72Q33981372-424057A0-0EF4-4844-A89C-149189D41CDFQ34033516-DF62DFA0-DC39-49BC-A94E-1A30F8351772Q34105297-BC2E0879-2267-4AE4-A4ED-5ADA46ECCC55Q34187557-0D3C2FB2-A536-411F-ADB2-D719EEE7C34DQ34574581-F1C97FC7-3A69-40EC-8CC8-65858B03990AQ34739025-FF65AC72-9F39-4415-BD06-289A391831BFQ35013334-444E8DBA-8EA5-4A13-BFB2-9E09D97F8C98Q35530029-67FC0E9D-9D25-472C-9D42-B4E87B9BBE8DQ35532764-2E1A93B3-7AB4-4BE5-BC47-145E43401BF1Q35560171-3D94F8D7-9F81-431F-BD7C-F95833350BCEQ35918396-D4FB0126-AA58-48A7-BE8B-0DC023C4D6B6Q36140694-1A9E89F8-E503-4135-97A7-21B679278FABQ36264883-D4551E8B-8AC0-464F-833D-F23C0827F45AQ36646072-9473A5DB-701F-4A38-9053-6C4C8A112496Q36979273-E5709427-59E5-42B7-A613-E1B1DC96282EQ37351865-5B59567F-2953-4238-82A4-94320ED69886Q37365815-7BE7FC58-A0B0-4410-8DED-0F22C3707952Q38034107-DD981408-4FB1-4FA8-8202-D9C946ABA16CQ38182645-71E66655-14CB-41F6-8F37-F628F0B1DF6DQ38212871-1F1257A1-49D3-4638-B66E-A3CB6F0E07F0Q38569559-1993D3A5-B275-4E23-A436-C0AB72EA7136Q38842992-0E3C13E7-AF12-4476-9035-98849144B965Q39272509-03697174-CF5E-4F7B-9316-1B708C5027CFQ39507297-BBD74C26-FF8F-4771-B919-1B816BFEED6DQ39808657-649845E2-A258-43D8-A503-5F89EC383073Q39827269-B51E0780-53A7-406C-8419-A1DE528E9516Q39827387-0854BBFD-312F-484F-8745-4E479D3ECA43Q40054411-DC73DFC2-1762-4D49-8EED-7AE7AD224E7AQ40065980-A936BC58-A2E9-465D-9E05-F7E0DDC8FAA4Q40246038-9419585D-0860-417B-AE23-24AB530EF919Q40303020-85D3295B-2081-4206-8C92-E3488B22049EQ40531502-3263DE07-4B9C-4288-A0F1-EED851FA435E
P2860
Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Intravenous immunoglobulin con ...... in superantigens [see comment]
@ast
Intravenous immunoglobulin con ...... in superantigens [see comment]
@en
type
label
Intravenous immunoglobulin con ...... in superantigens [see comment]
@ast
Intravenous immunoglobulin con ...... in superantigens [see comment]
@en
prefLabel
Intravenous immunoglobulin con ...... in superantigens [see comment]
@ast
Intravenous immunoglobulin con ...... in superantigens [see comment]
@en
P2093
P2860
P356
P1476
Intravenous immunoglobulin con ...... in superantigens [see comment]
@en
P2093
P2860
P304
P356
10.1172/JCI116240
P407
P577
1993-02-01T00:00:00Z